dewpoint logo

News

January 13, 2026
|
Category:

Excitement and confidence at Dewpoint in TDP-43 condensate modulator development candidate

The Pharma Letter features an article about Dewpoint Therapeutics, highlighting the excitement and confidence at the company in the selection of a development candidate (DC) for its TDP-43 program.

Read more about this significant milestone.

Media Contact

media@dewpointx.com

Investor Contact

IR@dewpointx.com